Long COVID Prevalence among U.S. Adults: A State-level Ecological Analysis of the Contribution of COVID-19 Incidence, Severity of Acute Illness, COVID-19 Vaccination, and Chronic Conditions
Preprint
Abstract
Background: Long COVID has emerged as a major public-health concern in the United States, yet geographic variation in its prevalence remains poorly understood. This study examines how state-level differences in COVID-19 vaccination, SARS-CoV-2 incidence, COVID-19 hospitalization, and chronic disease burden relate to adult Long COVID prevalence in the United States. Methods: We conducted an ecological analysis using data from the 2023 Behavioral Risk Factor Surveillance System (BRFSS), from which we estimated state-level prevalence of self-reported Long COVID among adults. These estimates were linked with publicly available data on SARS-CoV-2 incidence, COVID-19 hospitalizations, COVID-19 vaccine coverage, and a multimorbidity indicator (>= 3 chronic conditions e.g., diabetes, obesity, chronic kidney disease) associated with higher risk for severe SARS-CoV-2. Multivariable linear regression models were fitted to assess the contribution of each factor adjusted for age and sex distribution, incorporating Rubin’s rules to account for uncertainty in prevalence estimates. Results: All examined factors—including SARS-CoV-2 incidence, hospitalization rates, and multimorbidity, vaccine coverage—varied by state. When modeled simultaneously and adjusting for age and sex distribution, only COVID-19 vaccine coverage and SARS-CoV-2 incidence were significantly associated with Long COVID prevalence. COVID-19 vaccine coverage showed a strong protective association, while SARS-CoV-2 incidence showed a modest positive association. Multimorbidity and hospitalization rates were not independently associated with adjustment. Conclusions: State-level variation in Long COVID burden appears most strongly driven by COVID-19 vaccine coverage and SARS-CoV-2 incidence. Promoting COVID-19 vaccination remains essential to reduce long-term impacts from SARS-CoV-2 infections.Keywords
This publication has 18 references indexed in Scilit:
- Long Covid DefinedNew England Journal of Medicine, 2024
- Effect of COVID-19 vaccination on the risk of developing post-COVID conditions: The VENUS studyVaccine, 2024
- Prevalence, risk factors and characterisation of individuals with long COVID using Electronic Health Records in over 1.5 million COVID cases in EnglandJournal of Infection, 2024
- Complex patterns of multimorbidity associated with severe COVID-19 and long COVIDCommunications Medicine, 2024
- Risk Factors Associated With Post−COVID-19 ConditionJAMA Internal Medicine, 2023
- Association of Treatment With Nirmatrelvir and the Risk of Post–COVID-19 ConditionJAMA Internal Medicine, 2023
- Post-Acute Sequelae After Severe Acute Respiratory Syndrome Coronavirus 2 Infection by Viral Variant and Vaccination Status: A Multicenter Cross-Sectional StudyClinical Infectious Diseases, 2023
- Unreported SARS-CoV-2 Home Testing and Test PositivityJAMA Network Open, 2023
- Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic revieweClinicalMedicine, 2022
- Symptoms and risk factors for long COVID in non-hospitalized adultsNature Medicine, 2022